References
- 1. Vichinsky EP. Changing patterns of thalassemia worldwide. Am N Y Acad Sci. 2005; 1054: 18-24.
- 2. Fucharoen S, Winichagoon P. Prevention and control of thalassemia in Asia. Asian Biomed. 2007; 1:1-6.
- 3. Panich V, Pornpatkul M, Sriroongrueng W. The problem of thalassemia in Thailand. Southeast Asian J Trop Med Public Health. 1992; 23(Suppl 2):1-6.
- 4. Yang H, Kooi CD, Sokol PA. Ability of Pseudomonas pseudomallei malleobactin to acquire transferrinbound, lactoferrin-bound, and cell- derived iron. Infect Immun. 1998; 61:656-62.
- 5. Franchini M, Veneri D. Iron-chelation therapy: an update. Hematology J. 2004; 5:287-92.
- 6. Neufeld EL. Oral chelators deferasiox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2008; 107:3436-41.
- 7. Cox CD. Iron uptake with ferripyochelin and ferric citrate by Pseudomonas aeruginosa. J Bacteriol. 1980; 142:581-7.
- 8. Cox CD, Adams P. Siderophore activity of pyoverdin for Pseudomonas aeruginosa. Infect Immun. 1985; 48:130-8.
- 9. Sriyosachati S, Cox CD. Siderophore-mediated iron acquisition from transferrin by Pseudomonas aeruginosa. Infect Immun. 1986; 52:885-91.
- 10. Cox CD, Rinehart KL, Moore ML, Cook JCJr. Pyochelin: novel structure of an iron-chelating growth promoter for Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 1981; 78:4256-60.
- 11. Wendenbaum S, Demange P, Dell A, Meyer JM, Abdallah MA. The structure of pyoverdin Pa, the siderophore of Pseudomonas aeruginosa. Tetrahedron Lett. 1983; 24:4877-80.10.1016/S0040-4039(00)94031-0
- 12. Heinrich HP. The present state of iron-chelation therapy. In: Aksoy M, Birdwood GB, editors. Hypertransfusion and iron chelation in thalassemia. Stuttgart (Toronto):Hans Huber; 1985. p. 69-81.
- 13. Brock JH, Halliday JW, Pippard MJ, Powell LW. Iron metabolism in health and disease. London:WB. Saunders. 1994. p. 24-8, p. 63-5.
- 14. Menkin V. The role of the hydrogen ion concentration and the cytology of an exudate glycolysis in inflammation. Some aspects of the chemistry of exudates. In: Ryan EJ, editor. Biochemical mechanisms in inflammation. Springfield:Charles.C Thomas. 1956. p. 66-103.
- 15. Ankenbauer R, Sriyosachati S, Cox CD. Effects of siderophores on the growth of Pseudomonas aeruginosa in human serum and transferrin. Infect Immun. 1985; 49:132-40.
- 16. Castruita M, Elmegreen LA, Shaked Y, Stiefel EI, Morel FMM. Comparison of the kinetics of iron release from a marine (Trichodesmium erythraeum) Dps protein and mammalian ferritin in the presence and absence of ligands. J Inorg Biochem. 2007; 101:1686-91.
- 17. Almeida RS, Brunke S, Albrecht A, Thewes S, Laue M, Edwards JE, et al. The hyphal-associated adhesion and invasin Als of Candida albicans mediates iron acquisition from host ferritin. PLos Pathog 4, e1000217 (online), 2008. [cited 2008 Nov 21]. Available at: http://www.plospathogens:org/article/info:doi%2F10.1371%2Fjournal.ppat.1000217.
- 18. Cox CD, Graham R. Isolation of an iron-binding compound from Pseudomonas aeruginosa. J Bacteriol.1979; 137:357-64.
- 19. Ankenbauer R, Staley AL, Rinehart KL, Cox CD. Mutasynthesis of siderophore analogues by Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 1991; 88:1878-82.
- 20. Xiao G, Kisaalita WS. Iron acquisition from transferrin and lactoferrin by Pseudomonas aeruginosa pyoverdin. Microbiology. 1997. 143: 2509-15.